S&P 500 Nears Record High… And A Flex In The Weight Loss Drug Space 6/24/25

The first half of the year is in the books, and stocks closed it out touching fresh record highs. But can the climb continue in the back half? Where RBC’s Lori Calvasina sees the market heading next. Plus Oracle’s next move after the company announces some cloud deals, and a check on the China trade after the country’s manufacturing data shrinks for a 3rd straight month.Fast Money Disclaimer

The S&P 500 and Nasdaq both jump to fresh record highs, but pull back quickly as U.S.-Canada trade discussions screech to a halt. Plus Big bank stress test results, Nike’s best day since 2021, and Trump-Powell tensions run high, as Wall Street buzzes with potential for the president to name a Fed successor early. Fast Money Disclaimer

Stocks climbing across the board, with the S&P 500 just points away from a fresh record high. How a quiet stealth rally in one sector could push the index to new heights. Plus Nike results are out. The details and numbers from its latest quarter, and the new faces joining the coffee chain’s board of directors.Fast Money Disclaimer

Would you rather own Microsoft, Nvidia, or Apple? How our traders are navigating the moves in three of the largest companies in the world, as some hit record highs, and others lag behind the broader market. And speaking records, the S&P 500 just a whisper away from touching its own, and some individual names are paving the way. But are there more gains in store? The Fast Money crew lays out whether to Trade or Fade the winners.Fast Money Disclaimer

Stocks jumping as investors digested the latest Middle East developments, with the S&P 500 inching towards fresh record highs. The names leading the charger, and if the markets can reach new heights in the coming days. Plus A major flex in the weight loss drug space, as Scholar Rock boasts some new trial data. What the CEO says sets them apart from the competition. Fast Money Disclaimer

Crude oil sliding after Iran’s strike on a U.S. base in Qatar. The energy impact, and how the broader markets are reacting. Plus The next move for Novo Nordisk, as the pharma company cuts ties with Hims & Hers. What it means for the weight loss drug space, and how their latest trial data is hitting the stock.Fast Money Disclaimer

San Francisco Fed President Mary Daly and Fed Governor Christoper Waller weighing in on the central bank’s next rate move. What they had to say about an interest rate adjustment, and what it will mean for the market this summer. Plus Circle keeps soaring, after the Senate passed its stablecoin bill. What the landmark legislation means for the crypto space. Fast Money Disclaimer

The Fed keeps its interest rate steady, and one top bank analyst weighs in on the impact to financials. Plus, why Wall Street sees even more upside for Oracle, and the next move in energy as the Israel/Iran conflict throws oil prices into question. Fast Money Disclaimer

Stocks dropping as the Israel-Iran conflict rages on, with President Trump weighing in as well. How the developments in the Middle East are impacting markets, and how oil, bonds, and the dollar are faring. Plus The sun setting on solar stocks, as the Senate’s tax bill changes hit the group hard. If those names can rise again, or if the shadow is here to stay.Fast Money Disclaimer

Stocks kicking off the week in the green, as investors digest the latest from the Israel-Iran conflict. The names seeing the biggest moves, and if it will be the Mag7 or Legacy tech stocks that lead the market higher. Plus A biotech beatdown, as shares of Sarepta Therapeutics get hit. The headlines hitting that name, and where one top healthcare analyst sees the biotech and pharma space heading next.Fast Money Disclaimer